Effects of Sacubitril/Valsartan on Blood Pressure and Proteinuria in Hypertensive Patients With Chronic Kidney Disease.

J Clin Hypertens (Greenwich) · 2025 · PMC12277533 · PMID 40685715

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Among the 14 patients with a ≥10% decline in the eGFR, follow‐up data for 12 patients at 3 and 6 months showed a trend toward reductions in systolic BP and the UPCR over time (Figure 3B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.